2 leading COVID-19 treatments aren't working against omicron variant

Monoclonal antibody treatments that doctors used to prevent severe illness and hospitalizations may not be an option in the fight against omicron. Health leaders said COVID-19 antibody treatments made by Regeneron and Eli Lilly were found ineffective against omicron.

“We’ve given thousands of doses during the pandemic,” Dr. David Priest with Novant Health said. “[These treatments] are not going to be effective against the omicron variant, and these are the IV infusion treatments that healthcare systems have been using.”

This comes as COVID-19 cases in the North Carolina area are record-breaking with omicron continuing to spread through the state.

“We are seeing transmission at levels we have not seen before,” Mecklenburg County Health Director Dr. Raynard Washington said.

READ MORE: https://www.wcnc.com/article/news/health/coronavirus/monoclonal-antibody-treatment-covid-19-omicron/275-1f79a0a9-2ea8-4492-8aa4-a837b3b04879
Be the first to comment